Our 90-plus years of work in strategy and corporate finance have led us to develop innovative tools and approaches to help our clients stay ahead of the curve. We work with medical-technology companies to implement initiatives across portfolio strategy, innovation, growth strategy, transactions, due diligence, divestments, and activist-investor defense. Our deep understanding of value pools and trends in the industry coupled with our knowledge of disease treatments and health systems help clients build winning strategies.
We use distinctive industry knowledge, datasets, analytics, and benchmarks to deliver meaningful insights to clients.
Activist teardown: Assesses and identifies areas of activist pressure and provides an initial plan for addressing them.
Start-up and Analytics (SILA) Investment Landscape: An advanced analytics tool that rapidly develops a market map of companies and identifies key segments within a market and potential areas and target companies to pursue. Contact us to learn more
SynergyLab: Leverages external benchmarks and internal expertise to identify and quantify synergies within days, bringing insight into due diligence and initial integration plans.
Corporate-performance diagnostic: Develops a quantitative foundation for strategy discussions through financial data analysis of value-creation drivers. Learn more
